✦ LIBER ✦

Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

✍ Scribed by Andreas E. Albers; Robert L. Ferris; Grace G. Kim; Kazuaki Chikamatsu; Albert B. DeLeo; Theresa L. Whiteside

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 380 KB
Volume: 54
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-005-0670-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P53-specific T cell responses in patient

P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy

✍ Annechien Lambeck; Ninke Leffers; Baukje-Nynke Hoogeboom; Wim Sluiter; Ineke Ham 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 214 KB

## Abstract Despite intensive treatment, 70% of the ovarian cancer patients will develop recurrent disease, emphasizing the need for new approaches such as immunotherapy. A promising antigenic target for immunotherapy in ovarian cancer is the frequently overexpressed p53 protein. The aim of the stu

Long lasting p53-specific T cell memory

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer

✍ Sjoerd H. van der Burg; Karin de Cock; Anand G. Menon; Kees L. M. C Franken; Mar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

CD4+ T cell responses to HLA-DP5-restric

CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer

✍ Kazuaki Chikamatsu; Koichi Sakakura; Goro Takahashi; Atsushi Okamoto; Nobuhiko F 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 415 KB

p21-ras-peptide-specific T-cell response

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)

✍ Beate Fossum; Tobias Gedde-Dahl III; Jarle Breivik; Jon Amund Eriksen; Anne Spur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 979 KB

Peptides derived from mutated ras are immunogenic in mice and humans, and represent a group of specific tumor antigens that are potential targets for immunotherapy. T-cell responses against mutant p2I ras can be initiated in vitro by repeated stimulation of peripheral-blood mononuclear cells with mu